2 results
Approved WMOCompleted
The primary objective of this study is to test the hypothesis that evacetrapib 130 mg daily, in comparison to placebo, reduces the incidence of the composite endpoint of cardiovascular (CV) death, myocardial infarction (MI), stroke, coronary…
Approved WMORecruiting
The aim of this study is to assess the effects and side effects of the QWhet micro current wound stimulation device in up to 78 subjects with a chronic wound over a continuous period of 28 days.The collected (coded) data will be used by Q Care to…